Insurance Information

Cincinnati Children's strives to accept a wide variety of health plans. Please contact your health insurance carrier to verify coverage for your specific benefit plan.

View Insurance Information


Clinically available testing options resulting in diagnosis in post-exome clinic at one medical center. Baker, EK; Ulm, EA; Belonis, A; Brightman, DS; Hallinan, BE; Leslie, ND; Miethke, AG; Vawter-Lee, M; Wu, Y; Pena, LD M. Frontiers in Genetics. 2022; 13.

Systemic and ocular manifestations of a patient with mosaic ARID1A-associated Coffin-Siris syndrome and review of select mosaic conditions with ophthalmic manifestations. Utz, VM; Brightman, DS; Sandoval, MA; Hufnagel, R; Saal, HM. American Journal of Medical Genetics, Part C: Seminars in Medical Genetics. 2020; 184:644-655.

Growth Hormone Improves Short-Term Growth in Patients with Temple Syndrome. Brightman, DS; Lokulo-Sodipe, O; Searle, BA; Mackay, DJ G; Davies, JH; Temple, IK; Dauber, A. Hormone Research in Paediatrics. 2019; 90:407-413.

MLL1 is essential for retinal neurogenesis and horizontal inner neuron integrity. Brightman, DS; Grant, RL; Ruzycki, PA; Suzuki, R; Hennig, AK; Chen, S. Scientific Reports. 2018; 8.

Mosaic variegated aneuploidy syndrome caused by a CEP57 mutation diagnosed by whole exome sequencing. Brightman, DS; Ejaz, S; Dauber, A. Clinical Case Reports. 2018; 6:1531-1534.